These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10465590)

  • 1. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes.
    Kwon B; Youn BS; Kwon BS
    Curr Opin Immunol; 1999 Jun; 11(3):340-5. PubMed ID: 10465590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
    Gruss HJ; Duyster J; Herrmann F
    Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TNF-ligand and receptor superfamilies: controllers of immunity and the Trojan horses of autoimmune disease?
    Hill CM; Lunec J
    Mol Aspects Med; 1996 Oct; 17(5):455-509. PubMed ID: 9013494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor family ligand-receptor binding.
    Zhang G
    Curr Opin Struct Biol; 2004 Apr; 14(2):154-60. PubMed ID: 15093829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptor family members in the immune system.
    Gravestein LA; Borst J
    Semin Immunol; 1998 Dec; 10(6):423-34. PubMed ID: 9826575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lymphotoxin-beta-specific receptor.
    Crowe PD; VanArsdale TL; Walter BN; Ware CF; Hession C; Ehrenfels B; Browning JL; Din WS; Goodwin RG; Smith CA
    Science; 1994 Apr; 264(5159):707-10. PubMed ID: 8171323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural principles of tumor necrosis factor superfamily signaling.
    Vanamee ÉS; Faustman DL
    Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease.
    Lobito AA; Gabriel TL; Medema JP; Kimberley FC
    Trends Mol Med; 2011 Sep; 17(9):494-505. PubMed ID: 21724465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.
    Song K; Chen Y; Göke R; Wilmen A; Seidel C; Göke A; Hilliard B; Chen Y
    J Exp Med; 2000 Apr; 191(7):1095-104. PubMed ID: 10748228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TNF-TNF receptor system.
    Hehlgans T; Männel DN
    Biol Chem; 2002 Oct; 383(10):1581-5. PubMed ID: 12452434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand/I-Ealpha)-transgenic mice.
    Zhu G; Flies DB; Tamada K; Sun Y; Rodriguez M; Fu YX; Chen L
    J Immunol; 2001 Sep; 167(5):2671-6. PubMed ID: 11509610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins.
    Schneider P
    Methods Enzymol; 2000; 322():325-45. PubMed ID: 10914028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TNF ligand superfamily and its relevance for human diseases.
    Gruss HJ; Dower SK
    Cytokines Mol Ther; 1995 Jun; 1(2):75-105. PubMed ID: 9384666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TNF and TNF receptor superfamilies: integrating mammalian biology.
    Locksley RM; Killeen N; Lenardo MJ
    Cell; 2001 Feb; 104(4):487-501. PubMed ID: 11239407
    [No Abstract]   [Full Text] [Related]  

  • 18. Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes.
    Hasegawa H; Yamada Y; Harasawa H; Tsuji T; Murata K; Sugahara K; Tsuruda K; Masuda M; Takasu N; Kamihira S
    Cell Immunol; 2004; 231(1-2):1-7. PubMed ID: 15919363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases.
    Kwon B; Kim BS; Cho HR; Park JE; Kwon BS
    Exp Mol Med; 2003 Feb; 35(1):8-16. PubMed ID: 12642898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.
    Zhai Y; Guo R; Hsu TL; Yu GL; Ni J; Kwon BS; Jiang GW; Lu J; Tan J; Ugustus M; Carter K; Rojas L; Zhu F; Lincoln C; Endress G; Xing L; Wang S; Oh KO; Gentz R; Ruben S; Lippman ME; Hsieh SL; Yang D
    J Clin Invest; 1998 Sep; 102(6):1142-51. PubMed ID: 9739048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.